Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Notes Payables (2023 - 2026)

Updated

Translational Development Acquisition's Short-Term Borrowings came in at $1.1 million for Q2 2026, up 120.0% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Notes Payables (2023 - 2026) Analysis & Trends

At the end of FY2025, Translational Development Acquisition's Short-Term Borrowings was $200,000.

  • Going back by year, Short-Term Borrowings was $347,500 in FY2023.
  • Business Quant data shows TDACU's Short-Term Borrowings at $500,000 (Q1 2026), $200,000 (Q4 2025) and $100,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 500,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 100,000.00
Dec 31, 2023 347,500.00
API Access

Translational Development Acquisition Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=TDACU&period=max&api_key=YOUR_API_KEY